Jeffrey Finer, M.D., Ph.D

Jeffrey Finer, M.D., Ph.D

Chief Executive OfficeratSepterna· In proxies 2023–2025

Pay in FY2025-38% from the year before · Septerna stock +21.7% the same year

Jeffrey Finer, M.D., Ph.D was paid $2.9M in FY2025 (Dec), down 38%. Septerna stock rose 21.7% that year.

Pay$100 in the stock at the end of FY24 → $122
Pay is from the Summary Compensation Table of each Septerna proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. SepternaPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role +107%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?